Splanchnic arterial Doppler parameters in portal hypertension

Genomic profiling in hepatocellular carcinoma: a real-world retrospective analysis.

ESMO open·2025

Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab-bevacizumab resistance and worse survival in advanced hepatocarcinoma.

ESMO open·2025

Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial.

ESMO open·2025

Clinical impact of CEUS on non-characterizable observations and observations with intermediate probability of malignancy on CT/MRI in patients at risk for HCC.

Abdominal radiology (New York)·2024

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis.

ESMO open·2022

Taxanes hypersensitivity is not a risk factor for severe reactions to SARS-CoV-2 vaccines.

European annals of allergy and clinical immunology·2022

Shear wave elastography demonstrates similar risk stratification performance to vibration-controlled transient elastography in FIB-4-based two-step algorithms for MASLD.

Hepatology (Baltimore, Md.)·2026

A First-in-Human study of AHB-137, an unconjugated antisense oligonucleotide, in healthy subjects and patients with chronic hepatitis B.

Hepatology (Baltimore, Md.)·2026

Hepatocyte hnRNPK preserves mitochondrial integrity to restrain liver injury and fibrosis.

Hepatology (Baltimore, Md.)·2026

Liver-on-a-Chip: Applications for clinical modeling of liver disease using microscale systems.

Hepatology (Baltimore, Md.)·2026

BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.

Hepatology (Baltimore, Md.)·2026

With no lysine kinase 1 in hepatic stellate cells promotes mouse and human liver fibrosis through glycolytic triosephosphate isomerase 1.

Hepatology (Baltimore, Md.)·2026

Institutional and national Budget impact of alternative pembrolizumab dosing in non-small cell lung cancer: a real-world Pharmacoeconomic Analysis.

Expert review of pharmacoeconomics & outcomes research·2026

Attitudes of Older Patients and Caregivers in Japan Towards Deprescribing: A Cross-Sectional Study.

Geriatrics & gerontology international·2026

Comparative risk of new-onset diabetes between pravastatin and commonly used statins: A systematic review and meta-analysis.

The International journal of risk & safety in medicine·2026

Comparative Efficacy of Semaglutide and Tirzepatide in Chinese Adults with Obesity without Diabetes: A Real-World Observational Study.

Diabetes, metabolic syndrome and obesity : targets and therapy·2026

Primary aldosteronism and obstructive sleep apnea in hypertension: interplay, target organ damage, and clinical management.

Frontiers in endocrinology·2026

Bacterial Carriage and Invasive Infections Among People Who Inject Drugs: Clinical and Molecular Epidemiology in an Australian Prospective Cohort.

Open forum infectious diseases·2026

Related Experiment Videos

Splanchnic arterial Doppler parameters in portal hypertension

Related Concept Videos

Genomic profiling in hepatocellular carcinoma: a real-world retrospective analysis.

Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab-bevacizumab resistance and worse survival in advanced hepatocarcinoma.

Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial.

Clinical impact of CEUS on non-characterizable observations and observations with intermediate probability of malignancy on CT/MRI in patients at risk for HCC.

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis.

Taxanes hypersensitivity is not a risk factor for severe reactions to SARS-CoV-2 vaccines.

Shear wave elastography demonstrates similar risk stratification performance to vibration-controlled transient elastography in FIB-4-based two-step algorithms for MASLD.

A First-in-Human study of AHB-137, an unconjugated antisense oligonucleotide, in healthy subjects and patients with chronic hepatitis B.

Hepatocyte hnRNPK preserves mitochondrial integrity to restrain liver injury and fibrosis.

Liver-on-a-Chip: Applications for clinical modeling of liver disease using microscale systems.

BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.

With no lysine kinase 1 in hepatic stellate cells promotes mouse and human liver fibrosis through glycolytic triosephosphate isomerase 1.

Institutional and national Budget impact of alternative pembrolizumab dosing in non-small cell lung cancer: a real-world Pharmacoeconomic Analysis.

Attitudes of Older Patients and Caregivers in Japan Towards Deprescribing: A Cross-Sectional Study.

Comparative risk of new-onset diabetes between pravastatin and commonly used statins: A systematic review and meta-analysis.

Comparative Efficacy of Semaglutide and Tirzepatide in Chinese Adults with Obesity without Diabetes: A Real-World Observational Study.

Primary aldosteronism and obstructive sleep apnea in hypertension: interplay, target organ damage, and clinical management.

Bacterial Carriage and Invasive Infections Among People Who Inject Drugs: Clinical and Molecular Epidemiology in an Australian Prospective Cohort.

Related Experiment Videos

Splanchnic arterial Doppler parameters in portal hypertension

Related Concept Videos

Related Articles